Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Open-Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321 (NCT00391443)
Status: Enrolling
Updated:  9/9/2015
Pulmoary and Critical Care Medicine-Stanford University Medical Center
mi
from
Stanford, CA
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Open-Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321 (NCT00391443)
Status: Enrolling
Updated: 9/9/2015
Pulmoary and Critical Care Medicine-Stanford University Medical Center
mi
from
Stanford, CA
Click here to add this to my saved trials
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Open-Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321 (NCT00391443)
Status: Enrolling
Updated:  9/9/2015
National Jewish Medical and Research Center
mi
from
Denver, CO
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Open-Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321 (NCT00391443)
Status: Enrolling
Updated: 9/9/2015
National Jewish Medical and Research Center
mi
from
Denver, CO
Click here to add this to my saved trials
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Open-Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321 (NCT00391443)
Status: Enrolling
Updated:  9/9/2015
Yale University School of Medicine
mi
from
New Haven, CT
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Open-Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321 (NCT00391443)
Status: Enrolling
Updated: 9/9/2015
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Open-Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321 (NCT00391443)
Status: Enrolling
Updated:  9/9/2015
Emory University
mi
from
Atlanta, GA
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Open-Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321 (NCT00391443)
Status: Enrolling
Updated: 9/9/2015
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Open-Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321 (NCT00391443)
Status: Enrolling
Updated:  9/9/2015
University of Chicago
mi
from
Chicago, IL
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Open-Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321 (NCT00391443)
Status: Enrolling
Updated: 9/9/2015
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Open-Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321 (NCT00391443)
Status: Enrolling
Updated:  9/9/2015
Wichita Clinic
mi
from
Wichita, KA
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Open-Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321 (NCT00391443)
Status: Enrolling
Updated: 9/9/2015
Wichita Clinic
mi
from
Wichita, KA
Click here to add this to my saved trials
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Open-Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321 (NCT00391443)
Status: Enrolling
Updated:  9/9/2015
Beth Israel Deaconness Medical Center
mi
from
Boston, MA
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Open-Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321 (NCT00391443)
Status: Enrolling
Updated: 9/9/2015
Beth Israel Deaconness Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Open-Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321 (NCT00391443)
Status: Enrolling
Updated:  9/9/2015
University of Cinicinnati
mi
from
Cincinnati, OH
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Open-Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321 (NCT00391443)
Status: Enrolling
Updated: 9/9/2015
University of Cinicinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Open-Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321 (NCT00391443)
Status: Enrolling
Updated:  9/9/2015
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Open-Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321 (NCT00391443)
Status: Enrolling
Updated: 9/9/2015
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Open-Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321 (NCT00391443)
Status: Enrolling
Updated:  9/9/2015
The University of Pennsylvania Medical Center
mi
from
Philadelphia, PA
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Open-Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321 (NCT00391443)
Status: Enrolling
Updated: 9/9/2015
The University of Pennsylvania Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Open-Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321 (NCT00391443)
Status: Enrolling
Updated:  9/9/2015
Vanderbilt Medical Center - IPF Center
mi
from
Nashville, TN
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Open-Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321 (NCT00391443)
Status: Enrolling
Updated: 9/9/2015
Vanderbilt Medical Center - IPF Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Open-Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321 (NCT00391443)
Status: Enrolling
Updated:  9/9/2015
University of Texas-Southwestern Dallas-Div. of Pulm & Critical Care Unit
mi
from
Dallas, TX
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Open-Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321 (NCT00391443)
Status: Enrolling
Updated: 9/9/2015
University of Texas-Southwestern Dallas-Div. of Pulm & Critical Care Unit
mi
from
Dallas, TX
Click here to add this to my saved trials
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Open-Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321 (NCT00391443)
Status: Enrolling
Updated:  9/9/2015
Baylor College of Medicine
mi
from
Houston, TX
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Open-Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321 (NCT00391443)
Status: Enrolling
Updated: 9/9/2015
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Open-Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321 (NCT00391443)
Status: Enrolling
Updated:  9/9/2015
University of Utah
mi
from
Salt Lake City, UT
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Open-Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321 (NCT00391443)
Status: Enrolling
Updated: 9/9/2015
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Open-Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321 (NCT00391443)
Status: Enrolling
Updated:  9/9/2015
Inova Heart and Vascular Institute
mi
from
Falls Church, VA
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Open-Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321 (NCT00391443)
Status: Enrolling
Updated: 9/9/2015
Inova Heart and Vascular Institute
mi
from
Falls Church, VA
Click here to add this to my saved trials
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Open-Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321 (NCT00391443)
Status: Enrolling
Updated:  9/9/2015
University of Washington Medical Center
mi
from
Seattle, WA
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Open-Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321 (NCT00391443)
Status: Enrolling
Updated: 9/9/2015
University of Washington Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Open-Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321 (NCT00391443)
Status: Enrolling
Updated:  9/9/2015
University of Wisconsin-Madison
mi
from
Madison, WI
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Open-Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321 (NCT00391443)
Status: Enrolling
Updated: 9/9/2015
University of Wisconsin-Madison
mi
from
Madison, WI
Click here to add this to my saved trials
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Open-Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321 (NCT00391443)
Status: Enrolling
Updated:  9/9/2015
St. Vincent's Public Hospital, Lung Transplantation & Respiratory Medicine
mi
from
Darlinghurst,
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Open-Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321 (NCT00391443)
Status: Enrolling
Updated: 9/9/2015
St. Vincent's Public Hospital, Lung Transplantation & Respiratory Medicine
mi
from
Darlinghurst,
Click here to add this to my saved trials
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
A Phase 2, Randomized, Double-blind, Placebo-controlled, Efficacy and Safety Study of Inhaled JNJ 49095397 (RV568) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  9/10/2015
Clinical Research Facility
mi
from
Phoenix, AZ
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
A Phase 2, Randomized, Double-blind, Placebo-controlled, Efficacy and Safety Study of Inhaled JNJ 49095397 (RV568) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 9/10/2015
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
A Phase 2, Randomized, Double-blind, Placebo-controlled, Efficacy and Safety Study of Inhaled JNJ 49095397 (RV568) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  9/10/2015
Clinical Research Facility
mi
from
St. Louis, MO
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
A Phase 2, Randomized, Double-blind, Placebo-controlled, Efficacy and Safety Study of Inhaled JNJ 49095397 (RV568) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 9/10/2015
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
A Phase 2, Randomized, Double-blind, Placebo-controlled, Efficacy and Safety Study of Inhaled JNJ 49095397 (RV568) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  9/10/2015
Clinical Research Facility
mi
from
Chapel Hill, NC
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
A Phase 2, Randomized, Double-blind, Placebo-controlled, Efficacy and Safety Study of Inhaled JNJ 49095397 (RV568) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 9/10/2015
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
A Phase 2, Randomized, Double-blind, Placebo-controlled, Efficacy and Safety Study of Inhaled JNJ 49095397 (RV568) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  9/10/2015
Clinical Research Facility
mi
from
Charlotte, NC
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
A Phase 2, Randomized, Double-blind, Placebo-controlled, Efficacy and Safety Study of Inhaled JNJ 49095397 (RV568) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 9/10/2015
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
A Phase 2, Randomized, Double-blind, Placebo-controlled, Efficacy and Safety Study of Inhaled JNJ 49095397 (RV568) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  9/10/2015
Clinical Research Facility
mi
from
Cincinnati, OH
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
A Phase 2, Randomized, Double-blind, Placebo-controlled, Efficacy and Safety Study of Inhaled JNJ 49095397 (RV568) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 9/10/2015
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
A Phase 2, Randomized, Double-blind, Placebo-controlled, Efficacy and Safety Study of Inhaled JNJ 49095397 (RV568) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  9/10/2015
Clinical Research Facility
mi
from
Spartanburg, SC
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
A Phase 2, Randomized, Double-blind, Placebo-controlled, Efficacy and Safety Study of Inhaled JNJ 49095397 (RV568) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 9/10/2015
Clinical Research Facility
mi
from
Spartanburg, SC
Click here to add this to my saved trials
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
A Phase 2, Randomized, Double-blind, Placebo-controlled, Efficacy and Safety Study of Inhaled JNJ 49095397 (RV568) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  9/10/2015
mi
from
Antwerpen,
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
A Phase 2, Randomized, Double-blind, Placebo-controlled, Efficacy and Safety Study of Inhaled JNJ 49095397 (RV568) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 9/10/2015
mi
from
Antwerpen,
Click here to add this to my saved trials
Infant Pulmonary Mechanics: High Flow Nasal Cannula Versus Nasal CPAP
Pulmonary Mechanics in Preterm Infants Treated With Heated Humidified High Flow Nasal Cannula as Compared to Nasal Continuous Positive Airway Pressure.
Status: Enrolling
Updated:  9/14/2015
Pennsylvania Hospital
mi
from
Philadelphia, PA
Infant Pulmonary Mechanics: High Flow Nasal Cannula Versus Nasal CPAP
Pulmonary Mechanics in Preterm Infants Treated With Heated Humidified High Flow Nasal Cannula as Compared to Nasal Continuous Positive Airway Pressure.
Status: Enrolling
Updated: 9/14/2015
Pennsylvania Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Positioning of Surgical Patients With Sleep Apnea
Non-Supine Positioning in Treatment of Surgical Patients With Obstructive Sleep Apnea
Status: Enrolling
Updated:  9/14/2015
Englewood Hospital and Medical Center
mi
from
Englewood, NJ
Positioning of Surgical Patients With Sleep Apnea
Non-Supine Positioning in Treatment of Surgical Patients With Obstructive Sleep Apnea
Status: Enrolling
Updated: 9/14/2015
Englewood Hospital and Medical Center
mi
from
Englewood, NJ
Click here to add this to my saved trials
Stroke and CPAP Outcome Study: A Sham-controlled Trial of CPAP Among Stroke Rehabilitation Patients
Randomized Trial of Continuous Positive Airway Pressure in Patients Undergoing Intensive Inpatient Rehabilitation After Acute Stroke
Status: Enrolling
Updated:  9/15/2015
Univ of Washington
mi
from
Seattle, WA
Stroke and CPAP Outcome Study: A Sham-controlled Trial of CPAP Among Stroke Rehabilitation Patients
Randomized Trial of Continuous Positive Airway Pressure in Patients Undergoing Intensive Inpatient Rehabilitation After Acute Stroke
Status: Enrolling
Updated: 9/15/2015
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerbations in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/16/2015
CFF Adult Program University of Alabama
mi
from
Birmingham, AL
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerbations in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/16/2015
CFF Adult Program University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerbations in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/16/2015
CFF Care Center Arizona Health Science Center
mi
from
Tucson, AZ
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerbations in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/16/2015
CFF Care Center Arizona Health Science Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerbations in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/16/2015
National Jewish Health
mi
from
Denver, CO
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerbations in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/16/2015
National Jewish Health
mi
from
Denver, CO
Click here to add this to my saved trials
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerbations in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/16/2015
Johns Hopkins
mi
from
Baltimore, MD
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerbations in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/16/2015
Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerbations in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/16/2015
CFF Care Center & Pediatric Program Rainbow Babies and Children's Hospita
mi
from
Cleveland, OH
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerbations in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/16/2015
CFF Care Center & Pediatric Program Rainbow Babies and Children's Hospita
mi
from
Cleveland, OH
Click here to add this to my saved trials
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerbations in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/16/2015
Rainbow Babies and Children's Hospital / University Hospitals Case Medical Center
mi
from
Cleveland, OH
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerbations in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/16/2015
Rainbow Babies and Children's Hospital / University Hospitals Case Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerbations in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/16/2015
CFF Care Center & Pediatric Program Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerbations in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/16/2015
CFF Care Center & Pediatric Program Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerbations in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/16/2015
Medical University of South Carolina
mi
from
Charleston, SC
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerbations in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/16/2015
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerbations in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/16/2015
CFF Care Center & Pediatric Program The University of Texas Southwestern Medical Center at Dallas
mi
from
Dallas, TX
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerbations in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/16/2015
CFF Care Center & Pediatric Program The University of Texas Southwestern Medical Center at Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerbations in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/16/2015
CFF Care Center & Pediatric Program Seattle Children's Hospital
mi
from
Seattle, WA
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerbations in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/16/2015
CFF Care Center & Pediatric Program Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerbations in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/16/2015
Univ of Washington
mi
from
Seattle, WA
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerbations in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/16/2015
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerbations in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/16/2015
CFF Care Center & Pediatric Program University of Wisconsin
mi
from
Madison, WI
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerbations in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/16/2015
CFF Care Center & Pediatric Program University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Mesenchymal Stem Cell Therapy for Lung Rejection
A Pilot Study to Evaluate the Safety and Feasibility of Mesenchymal Stem Cells to Induce Remission in Lung Transplant Patients Experiencing Treatment-refractory Moderate Lung Rejection
Status: Enrolling
Updated:  9/21/2015
Mayo Clinic Florida
mi
from
Jacksonville, FL
Mesenchymal Stem Cell Therapy for Lung Rejection
A Pilot Study to Evaluate the Safety and Feasibility of Mesenchymal Stem Cells to Induce Remission in Lung Transplant Patients Experiencing Treatment-refractory Moderate Lung Rejection
Status: Enrolling
Updated: 9/21/2015
Mayo Clinic Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Lung Injury Prediction Study
Identifying Patients at Risk of Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS) at the Time of Hospital Admission: External Validation of a Lung Injury Prediction Score (LIPS)
Status: Enrolling
Updated:  9/22/2015
The Mayo Clinic
mi
from
Rochester, MN
Lung Injury Prediction Study
Identifying Patients at Risk of Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS) at the Time of Hospital Admission: External Validation of a Lung Injury Prediction Score (LIPS)
Status: Enrolling
Updated: 9/22/2015
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent VLP Influenza Vaccine in Adults
Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent Virus-like-particle (VLP) Influenza Vaccine in Adults
Status: Enrolling
Updated:  9/24/2015
Miami Research Associates
mi
from
Miami, FL
Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent VLP Influenza Vaccine in Adults
Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent Virus-like-particle (VLP) Influenza Vaccine in Adults
Status: Enrolling
Updated: 9/24/2015
Miami Research Associates
mi
from
Miami, FL
Click here to add this to my saved trials
Evaluation of Danirixin (GSK1325756) Inhibition of CD11b Cell Surface Expression
A Single-Center In Vitro Study to Evaluate GSK1325756 Inhibition of CD11b Cell Surface Expression in Healthy Adults and Respiratory Syncytial Virus-Infected Children <2 Years (200591)
Status: Enrolling
Updated:  9/24/2015
GSK Investigational Site
mi
from
Syracuse, NY
Evaluation of Danirixin (GSK1325756) Inhibition of CD11b Cell Surface Expression
A Single-Center In Vitro Study to Evaluate GSK1325756 Inhibition of CD11b Cell Surface Expression in Healthy Adults and Respiratory Syncytial Virus-Infected Children <2 Years (200591)
Status: Enrolling
Updated: 9/24/2015
GSK Investigational Site
mi
from
Syracuse, NY
Click here to add this to my saved trials
Baby Observational and Nutritional Study
Baby Observational and Nutritional Study (BONUS)
Status: Enrolling
Updated:  9/25/2015
University of Alabama at Birmingham
mi
from
Birmingham, AL
Baby Observational and Nutritional Study
Baby Observational and Nutritional Study (BONUS)
Status: Enrolling
Updated: 9/25/2015
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Baby Observational and Nutritional Study
Baby Observational and Nutritional Study (BONUS)
Status: Enrolling
Updated:  9/25/2015
Arkansas Children's Hospital
mi
from
Little Rock, AR
Baby Observational and Nutritional Study
Baby Observational and Nutritional Study (BONUS)
Status: Enrolling
Updated: 9/25/2015
Arkansas Children's Hospital
mi
from
Little Rock, AR
Click here to add this to my saved trials
Baby Observational and Nutritional Study
Baby Observational and Nutritional Study (BONUS)
Status: Enrolling
Updated:  9/25/2015
Children's Hospital Colorado
mi
from
Aurora, CO
Baby Observational and Nutritional Study
Baby Observational and Nutritional Study (BONUS)
Status: Enrolling
Updated: 9/25/2015
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Baby Observational and Nutritional Study
Baby Observational and Nutritional Study (BONUS)
Status: Enrolling
Updated:  9/25/2015
Emory CF Center
mi
from
Atlanta, GA
Baby Observational and Nutritional Study
Baby Observational and Nutritional Study (BONUS)
Status: Enrolling
Updated: 9/25/2015
Emory CF Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Baby Observational and Nutritional Study
Baby Observational and Nutritional Study (BONUS)
Status: Enrolling
Updated:  9/25/2015
Riley Hospital for Children
mi
from
Indianapolis, IN
Baby Observational and Nutritional Study
Baby Observational and Nutritional Study (BONUS)
Status: Enrolling
Updated: 9/25/2015
Riley Hospital for Children
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Baby Observational and Nutritional Study
Baby Observational and Nutritional Study (BONUS)
Status: Enrolling
Updated:  9/25/2015
University of Michigan
mi
from
Ann Arbor, MI
Baby Observational and Nutritional Study
Baby Observational and Nutritional Study (BONUS)
Status: Enrolling
Updated: 9/25/2015
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials